Proteomic profiling of autoantibodies in patients with esophageal squamous cell carcinoma
食管鳞状细胞癌患者自身抗体的蛋白质组学分析
基本信息
- 批准号:18591465
- 负责人:
- 金额:$ 2.57万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To identify proteins associated with esophageal carcinogenesis, we performed protein profiling of 16 esophageal squamous cell carcinomas (ESCCs) and paired non-cancerous tissues by two-dimensional electrophoresis (2-DE) and tandem mass spectrometry. In cancerous tissues, three spots showed significant up-regulation in the amount of protein, while eight spots were significantly down-regulated. The identities of the spots were determined by peptide mass fingerprinting (PMF) with liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and were confirmed by immunoblotting. The up-regulated proteins were tropomyosin alpha 4 chain, transgelin, and pyruvate kinase. The down-regulated proteins were serum albumin precursor, isoforms of annexin Al, tropomyosin beta chain, 14-3-3 protein sigma and isoforms of serotransferrin precursor. In all 16 cases, up-regulation of the tropomyosin alpha 4 chain was confirmed by immunoblotting. Localization of the tropomyosin alpha 4 chain in ESCC cells and adjacent fibroblasts was confirmed by immunohistochemistry.
为了鉴定与食管癌发生相关的蛋白质,我们采用双向电泳(2-DE)和串联质谱法对16例食管鳞状细胞癌(ESCC)和配对的非癌组织进行了蛋白质谱分析。在癌组织中,三个点显示蛋白质量显著上调,而八个点显著下调。通过液相色谱-质谱/质谱(LC-MS/MS)的肽质量指纹图谱(PMF)确定斑点的身份,并通过免疫印迹法进行确认。表达上调的蛋白质为原肌球蛋白α 4链、转凝胶蛋白和丙酮酸激酶。下调的蛋白质为血清白蛋白前体、膜联蛋白A1亚型、原肌球蛋白β链、14-3-3蛋白σ和血清转铁蛋白前体亚型。在所有16例病例中,通过免疫印迹证实了原肌球蛋白α 4链的上调。原肌球蛋白α 4链在食管鳞癌细胞和邻近的成纤维细胞中的定位通过免疫组织化学证实。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma
- DOI:10.1002/pmic.200500346
- 发表时间:2006-07-01
- 期刊:
- 影响因子:3.4
- 作者:Takashima, Motonari;Kuramitsu, Yasuhiro;Nakamura, Kazuyuki
- 通讯作者:Nakamura, Kazuyuki
Analysis for Auoantibodies in Sera from esophagus Squamous Cell Carcinoma-Bearing Patients
食管鳞状细胞癌患者血清中抗体的分析
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Toshio;Harada
- 通讯作者:Harada
高齢者食道癌における食道切除術症例の検討
老年食管癌切除术病例研究
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Shigeru;Takeda;原田 俊夫;武田 茂;高島元成;蔵満保宏;武田 茂;武田茂;武田 茂
- 通讯作者:武田 茂
Expression of tropomyosin alpha 4 chain is increased in esophageal squamous cell carcinoma as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry
- DOI:10.1002/prca.200600609
- 发表时间:2007-02-01
- 期刊:
- 影响因子:2
- 作者:Harada, Toshio;Kuramitsu, Yasuhiro;Nakamura, Kazuyuki
- 通讯作者:Nakamura, Kazuyuki
A clinical study of esophagectomy after chemo-radiation therapy for advanted esophageal carcinoma
晚期食管癌放化疗后食管切除术的临床研究
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Shigeru;Takeda;原田 俊夫;武田 茂
- 通讯作者:武田 茂
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKEDA Shigeru其他文献
TAKEDA Shigeru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKEDA Shigeru', 18)}}的其他基金
Association of single nucleotide polymorphisms in the diamine oxidase gene with gastrointestinal toxicity during chemotherapy in patients with esophageal carcinoma
二胺氧化酶基因单核苷酸多态性与食管癌化疗期间胃肠道毒性的关系
- 批准号:
15K10102 - 财政年份:2015
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The clinical significance of serum diamine oxidase(DAO) activity during chemotherapy in patients with carcinoma
癌症患者化疗期间血清二胺氧化酶(DAO)活性的临床意义
- 批准号:
22591455 - 财政年份:2010
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Active Support for Linear Collider
对线性对撞机的主动支持
- 批准号:
10554010 - 财政年份:1998
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
相似海外基金
Point-of-Care Diagnosis of Esophageal Cancer in LMICs
中低收入国家食管癌的即时诊断
- 批准号:
10649166 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Clinical impact of Leucine-Rich alpha-2 Glycoprotein in patients with esophageal cancer
富含亮氨酸的 α-2 糖蛋白对食管癌患者的临床影响
- 批准号:
23K15487 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Basic research for macrophage immune check point inhibition as a novel esophageal cancer therapy
巨噬细胞免疫检查点抑制作为食管癌新型疗法的基础研究
- 批准号:
23K15525 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Depletion of tumor suppressor miRNAs in blood relates to tumor progression and poor outcomes in esophageal cancer
血液中抑癌 miRNA 的消耗与食管癌的肿瘤进展和不良预后相关
- 批准号:
23K06700 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Overcoming the drug resistance through drug repositioning in esophageal cancer
通过药物重新定位克服食管癌耐药性
- 批准号:
23K08221 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a Postoperative Patient Support System for Esophageal Cancer Using Metaverse
使用 Metaverse 开发食管癌术后患者支持系统
- 批准号:
23H03197 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of retroviral replicating vector-mediated liver-expressed iron-regulating peptide hormone, hepcidine gene therapy for esophageal cancer.
开发逆转录病毒复制载体介导的肝脏表达的铁调节肽激素、食道癌的铁碱基因疗法。
- 批准号:
23K08184 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of tight junction in metastasis of esophageal cancer
紧密连接在食管癌转移中的作用
- 批准号:
23K14593 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of tumor microbiome and mechanism of malignant transformation in esophageal cancer
食管癌肿瘤微生物组及恶变机制分析
- 批准号:
23K08129 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer
HORMAD 特异性 TGF-β 耐药性记忆 T 细胞用于治疗胃食管癌患者
- 批准号:
10731407 - 财政年份:2023
- 资助金额:
$ 2.57万 - 项目类别: